High dose celecoxib and metronomic 'low-dose' cyclophosphamide is effective therapy in patients with relapsed and refractory aggressive histology NHL.

被引：0
|
作者：
Buckstein, R
Crump, M
Shaked, Y
Spaner, D
Piliotis, E
Imrie, K
Nayar, R
Foden, C
Turner, R
Taylor, D
Man, S
Baruchel, S
Stempak, D
Quirt, I
Sturgeon, J
Bertolini, F
Kerbel, RS
机构：
[1] Toronto Sunnybrook Reg Canc Ctr, Toronto, ON, Canada
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[3] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[4] European Inst Oncol, Milan, Italy
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：239B / 239B
页数：1
相关论文
共 50 条
  • [1] High dose celecoxib and metronomic "low dose" cyclophosphamide is effective and safe therapy in patients with relapsed and refractory aggressive histology NHL
    Buckstein, R
    Crump, M
    Shaked, Y
    Foden, C
    Turner, R
    Taylor, D
    Man, S
    Bertolini, F
    Kerbel, R
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 134 - 135
  • [2] Palliation of relapsed aggressive histology NHL with high-dose celecoxib and 'metronomic' low-dose cyclophosphamide.
    Buckstein, R
    Crump, M
    Shaked, Y
    Foden, C
    Nayar, R
    Taylor, D
    Bertolini, F
    Baruchel, S
    Man, S
    Kerbel, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 199S - 199S
  • [3] High-dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin's lymphoma
    Buckstein, Rena
    Kerbel, Robert S.
    Shaked, Yuval
    Nayar, Rakesh
    Foden, Cindy
    Turner, Ruth
    Lee, Christine R.
    Taylor, Diane
    Zhang, Liying
    Man, Shan
    Baruchel, Sylvain
    Stempak, Diana
    Bertolini, Francesco
    Crump, Michael
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (17) : 5190 - 5198
  • [4] Phase II study of 'high-dose' celecoxib and metronomic 'low-dose' cyclophosphamide and methotrexate in patients with relapsed and refractory lymphoma
    Abdel-Bary, N.
    Hashem, T.
    Metwali, H.
    Abd el Ghany, A.
    Magied, H. A.
    El-Herbeiny, M.
    [J]. ECANCERMEDICALSCIENCE, 2009, 3
  • [5] LOW-DOSE THALIDOMIDE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Kohei, K. O.
    Ando, S.
    Hasino, S.
    Huse, H.
    Morita, R.
    Takahata, M.
    Onozawa, M.
    Kahata, K.
    Kondo, T.
    Ota, S.
    Kawamura, T.
    Kurosawa, M.
    Aikawa, K.
    Ogawa, T.
    Suzuki, S.
    Takahashi, S.
    Izumiyama, K.
    Iwasaki, H.
    Maemori, M.
    Sakai, H.
    Asaka, M.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 619 - 620
  • [6] Low-dose of Ruxolitinib: An Effective Therapy for Refractory Bos Patients
    Ji, Yanping
    Tang, Baolin
    Zhu, Xiaoyu
    Liu, Huilan
    Song, Kaidi
    Wan, Xiang
    Yao, Wen
    Sun, Guangyu
    Sun, Zimin
    [J]. BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 370 - 370
  • [7] Pharmacodynamic and pharmacokinetic study of chronic low-dose metronomic cyclophosphamide therapy in mice
    Emmenegger, Urban
    Shaked, Yuval
    Man, Shan
    Bocci, Guido
    Spasojevic, Ivan
    Francia, Giulio
    Kouri, Andrew
    Coke, Robert
    Cruz-Munoz, William
    Ludeman, Susan M.
    Colvin, O. Michael
    Kerbel, Robert S.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2007, 6 (08) : 2280 - 2289
  • [8] High dose etoposide and cyclophosphamide therapy in refractory/relapsed lymphomas - An update of 85 patients
    Cohen, S
    Lacroix, L
    Blake, G
    Rybka, W
    Caplan, S
    Laneuville, P
    [J]. BLOOD, 1997, 90 (10) : 849 - 849
  • [9] Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response
    Herman Andres Perroud
    Carlos Maria Alasino
    Maria Jose Rico
    Leandro Ernesto Mainetti
    Francisco Queralt
    Stella Maris Pezzotto
    Viviana Rosa Rozados
    O. Graciela Scharovsky
    [J]. Cancer Chemotherapy and Pharmacology, 2016, 77 : 365 - 374
  • [10] Metronomic therapy for refractory/relapsed lymphoma: the PEP-C low-dose oral combination chemotherapy regimen
    Coleman, Morton
    Ruan, Gia
    Elstrom, Rebecca L.
    Martin, Peter
    Leonard, John P.
    [J]. HEMATOLOGY, 2012, 17 : S90 - S92
12345